- Home
- SAVA vs OGI Comparison
SAVA vs OGI Comparison
Compare SAVA & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- OGI
- Stock Information
- Founded
- SAVA 1998
- OGI 2013
- Country
- SAVA United States
- OGI Canada
- Employees
- SAVA N/A
- OGI N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- SAVA Health Care
- OGI Health Care
- Exchange
- SAVA Nasdaq
- OGI Nasdaq
- Market Cap
- SAVA 70.5M
- OGI 155.2M
- IPO Year
- SAVA N/A
- OGI N/A
- Fundamental
- Price
- SAVA $1.76
- OGI $1.17
- Analyst Decision
- SAVA Buy
- OGI
- Analyst Count
- SAVA 3
- OGI 0
- Target Price
- SAVA $54.50
- OGI N/A
- AVG Volume (30 Days)
- SAVA 807.5K
- OGI 369.3K
- Earning Date
- SAVA 05-08-2025
- OGI 05-12-2025
- Dividend Yield
- SAVA N/A
- OGI N/A
- EPS Growth
- SAVA N/A
- OGI N/A
- EPS
- SAVA N/A
- OGI N/A
- Revenue
- SAVA N/A
- OGI $115,451,336.00
- Revenue This Year
- SAVA N/A
- OGI $50.30
- Revenue Next Year
- SAVA N/A
- OGI $16.01
- P/E Ratio
- SAVA N/A
- OGI N/A
- Revenue Growth
- SAVA N/A
- OGI N/A
- 52 Week Low
- SAVA $1.15
- OGI $0.85
- 52 Week High
- SAVA $42.20
- OGI $2.11
- Technical
- Relative Strength Index (RSI)
- SAVA 54.92
- OGI 54.62
- Support Level
- SAVA $1.45
- OGI $1.09
- Resistance Level
- SAVA $1.67
- OGI $1.16
- Average True Range (ATR)
- SAVA 0.11
- OGI 0.05
- MACD
- SAVA 0.05
- OGI 0.00
- Stochastic Oscillator
- SAVA 87.50
- OGI 57.65
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.